SCHEMBL25695746

SCHEMBL25695746

Cc1ccc(CCN(C)Cc2cccc(N)c2)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 10/20 0.51
▸ ATM Q13315 1/20 0.44
▸ CYP1A2 P05177 4/20 0.43
▸ TP53 P04637 3/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ CYP19A1 P11511 1/20 0.43
▸ HTR7 P34969 1/20 0.43
▸ CYP3A4 P08684 3/20 0.42
▸ ROCK1 Q13464 1/20 0.42
▸ AOC3 Q16853 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ CYP2D6 P10635 3/20 0.40
▸ TSHR P16473 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30219730 0.83 SIGMAR1 (0.44) SIGMAR1ATMCYP1A2TP53MEN1
SCHEMBL24046693 0.83 SIGMAR1 (0.44) SIGMAR1ATMCYP1A2TP53MEN1
SCHEMBL8790689 0.76 KDM4E (0.67) SIGMAR1CYP1A2MEN1ALDH1A1KMT2A
SCHEMBL25695757 0.75 CYP1A2 (0.46) SIGMAR1CYP1A2MAPTCYP2C19CYP19A1
SCHEMBL374305 0.74 ALDH1A1 (0.49) SIGMAR1ATMMEN1ALDH1A1CYP2C19
SCHEMBL7976714 0.72 HSD11B1 (0.45) SIGMAR1CYP2C19CYP19A1ROCK1MAOA
SCHEMBL31480967 0.71 TAAR1 (0.61) SIGMAR1CYP19A1HTR7AOC3MAOA
SCHEMBL529408 0.71 TAAR1 (0.61) SIGMAR1CYP19A1HTR7AOC3MAOA
Hydrochloric Acid SCHEMBL15954500 0.71 MAOA (0.44) SIGMAR1CYP2C19CYP19A1MAOAMAOB
SCHEMBL18556823 0.71 GRIN2D (0.48) SIGMAR1MAPTKMT2ACYP19A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192644-A1 PIPERIDINE-2,6-DIONES AS SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192644-A1 PIPERIDINE-2,6-DIONES AS SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE IKZF2, IKZF1, NUTF2 SIGMAR1 3171/4885ATM 4632/4885CYP1A2 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback